Dextrans for targeted and sustained delivery of therapeutic and imaging agents.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Controlled Release

• Publication date

  2000-10-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0168-3659(00)00302-3PMID 11018543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blood levels and serum protein binding of cis-Platinum(II) complexed to carboxymethyl-dextran

  2004cited by this paper
• Synthesis and Pharmacokinetics of a New Liver-Specific Carrier, Glycosylated Carboxymethyl-Dextran, and Its Application to Drug Targeting

  2004cited by this paper
• Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes.

  2000cited by this paper
• Reduced immunogenicity of beta-lactoglobulin by conjugation with carboxymethyl dextran.

  2000cited by this paper
• Reduced Immunogenicity of β-Lactoglobulin by Conjugation with Carboxymethyl Dextran

  2000cited by this paper
• Tc-99m dextran: a new and sensitive general purpose scintigraphic agent for diagnosing intestinal inflammation.

  1999cited by this paper
• In vitro characteristics and in vivo plasma disposition of cisplatin conjugated with oxidized and dicarboxymethylated dextrans.

  1999cited by this paper
• Effect of a conjugate of polymyxin B-dextran 70 in horses with experimentally induced endotoxemia.

  1999cited by this paper
• The effects of stroma-free and dextran-conjugated hemoglobin on hemodynamics and carotid blood flow in hemorrhaged guinea pigs.

  1999cited by this paper
• Simultaneous analysis of dextran-methylprednisolone succinate, methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography.

  1999cited by this paper
• Synthesis and pharmacokinetics of a novel macromolecular prodrug of Tacrolimus (FK506), FK506-dextran conjugate.

  1999cited by this paper
• Lowering of trichosanthin immunogenicity by site-specific coupling to dextran.

  1999cited by this paper
• Extending insulin action in vivo by conjugation to carboxymethyl dextran.

  1998cited by this paper
• Cytotoxicity and DNA binding characteristics of dextran-conjugated doxorubicins.

  1998cited by this paper
• Polymeric conjugates of Gd(3+)-diethylenetriaminepentaacetic acid and dextran. 2. Influence of spacer arm length and conjugate molecular mass on the paramagnetic properties and some biological parameters.

  1998cited by this paper
• Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoural injection.

  1998cited by this paper
• Dextran–estrone conjugate: synthesis and in vitro release study

  1998cited by this paper
• Renal imaging with 99Tc(m)-dextran.

  1997cited by this paper
• Polymyxin-dextran antiendotoxin pretreatment in an ovine model of normotensive sepsis.

  1997cited by this paper
• Polymeric conjugates of Gd(3+)-diethylenetriaminepentaacetic acid and dextran. 1. Synthesis, characterization, and paramagnetic properties.

  1997cited by this paper
• Polysaccharides as drug carriers: biodisposition of fluorescein-labeled dextrans in mice.

  1997cited by this paper
• Renal imaging with 99Tcm-dextran

  1997cited by this paper
• Kinetics of hepatic accumulation of dextrans in isolated perfused rat livers.

  1997cited by this paper
• Delayed therapy with a polymyxin B-dextran conjugate (PMX-622) improves survival in rabbits with Gram-negative peritonitis

  1997cited by this paper
• The potential of radiolabeled EGF‐dextran conjugates in the treatment of urinary bladder carcinoma

  1997cited by this paper
• Synthesis and cytotoxic activity of dextran carrying cis-dichloro(cyclohexane-trans-l-1,2-diamine)platinum(II) complex.

  1996cited by this paper
• Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits.

  1996cited by this paper
• Receptor-mediated absorption of high molecular weight dextrans from intestinal tract

  1996cited by this paper
• The crucial role of spacer groups in macromolecular prodrug design

  1996cited by this paper
• Dextran modification of a Fab'--beta-lactamase conjugate modulated by variable pretreatment of Fab' with amine-blocking reagents.

  1996cited by this paper
• Targeted hyperthermia using dextran magnetite complex: a new treatment modality for liver tumors.

  1996cited by this paper
• Sustained release of recombinant human growth hormone from dextran via hydrolysis of an imine bond

  1996cited by this paper
• Synthesis and Cytotoxic Activity of Dextran-Immobilizing Platinum(II) Complex Through Chelate-Type Coordination Bond

  1996cited by this paper
• Scintigraphic diagnosis of gastrointestinal bleeding with 99Tcm-dextran.

  1996cited by this paper
• Partial synergism between dextran-conjugated doxorubicin and cancer drugs on the killing of multidrug resistant KB-V1 cells.

  1996cited by this paper
• Synthesis of polyglutamine and dextran conjugates of streptomycin with an acid-sensitive drug-carrier linkage.

  1996cited by this paper
• Technetium-99m dextran: a promising new protein-losing enteropathy imaging agent

  1996cited by this paper
• Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia

  1995cited by this paper
• Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties.

  1995cited by this paper
• Body distribution of dextran derivatives with electric charges after intravenous administration

  1995cited by this paper
• 99Tcm-dextran: A potential inflammation‐seeking radiopharmaceutical

  1995cited by this paper
• Pharmacokinetics of glutathione-dextran macromolecular conjugate in mice.

  1995cited by this paper
• Altered pharmacokinetic and tumour localization properties of Fab' fragments of a murine monoclonal anti‐CEA antibody by covalent modification with low molecular weight dextran

  1995cited by this paper
• Dose dependency of the kinetics of dextrans in rats: effects of molecular weight.

  1995cited by this paper
• Assessment of dextran 10-benzene-tetracarboxylate-hemoglobin, an oxygen carrier, using guinea pig isolated bowel model.

  1995cited by this paper
• Paramagnetic dextrans as magnetic resonance blood pool tracers.

  1994cited by this paper
• Tissue distribution of macromolecular conjugate, adriamycin linked to oxidized dextran, in rat and mouse bearing tumor cells.

  1994cited by this paper
• Development of intra-arterial hyperthermia using a dextran-magnetite complex.

  1994cited by this paper
• Molecular weight dependent tissue accumulation of dextrans: in vivo studies in rats.

  1994cited by this paper
• Human hemoglobin conjugated to carboxylate dextran as a potential red blood cell substitute. II--Pharmacotoxicological evaluation.

  1994cited by this paper
• Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.

  1994cited by this paper
• Preparation of dextran 70 injection labeled with technetium 99m for use as a cardiac blood-pool imaging agent.

  1994cited by this paper
• A protective effect of glutathione-dextran macromolecular conjugates on acetaminophen-induced hepatotoxicity dependent on molecular size.

  1994cited by this paper
• Properties of soluble glutathione-dextran conjugates as a macromolecular prodrug dependent on the linkage structure.

  1994cited by this paper
• Glucocorticoid‐dextran conjugates as potential prodrugs for colonspecific delivery: Steady‐state pharmacokinetics in the rat

  1994cited by this paper
• Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.

  1994cited by this paper
• The biological activities of trichosanthin after coupling to dextran.

  1993cited by this paper
• Body distribution profile of polysaccharides after intravenous administration

  1993cited by this paper
• Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)

  1993cited by this paper
• Synthesis and chemical stability of glucocorticoid-dextran esters: potential prodrugs for colon-specific delivery

  1993cited by this paper
• Modulation of trichosanthin antigenicity by coupling to dextran.

  1992cited by this paper
• Synthesis, characterization and release of cromoglycate from dextran conjugates

  1992cited by this paper
• Demonstration of the Receptor‐mediated Hepatic Uptake of Dextran in Mice

  1992cited by this paper
• Release of cromoglycate from dextran and inulin conjugates

  1992cited by this paper
• Multiple Oral Administration of a Ketoprofen–Dextran Ester Prodrug in Pigs: Assessment of Gastrointestinal Unavailability by Deconvolution

  1992cited by this paper
• Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion.

  1992cited by this paper
• Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats.

  1992cited by this paper
• Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives.

  1992cited by this paper
• Enhanced intracellular stability of dextran-horse radish peroxidase conjugate: an approach to enzyme replacement therapy.

  1992cited by this paper
• Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo.

  1992cited by this paper
• Hepatic Disposition Characteristics of Electrically Charged Macromolecules in Rat in Vivo and in the Perfused Liver

  1991cited by this paper
• Properties of asparaginase-dextran conjugates

  1991cited by this paper
• Conjugate of N4-(4-carboxybutyryl)-ara-C and ethylenediamine-introduced dextran. Drug release profiles and further in vivo study of its antitumor effects.

  1991cited by this paper
• Stability of ketoprofen-dextran ester prodrugs in homogenates of various segments of the pig GI tract.

  1991cited by this paper
• Comparative Pharmacokinetic Properties of Murine Monoclonal Antibody A7 Modified with Neocarzinostatin, Dextran and Polyethylene Glycol

  1991cited by this paper
• Binding of epidermal growth factor‐dextran conjugates to cultured glioma cells

  1991cited by this paper
• Bioavailability of ketoprofen from orally administered ketoprofen-dextran ester prodrugs in the pig.

  1991cited by this paper
• Fate of glycosylated dextrans after in vivo administration

  1991cited by this paper
• Tissue distribution of 111In-labeled uricase conjugated with charged dextrans and polyethylene glycol.

  1991cited by this paper
• Increasing the plasma half-life of trichosanthin by coupling to dextran.

  1991cited by this paper
• EFFECT OF ELECTRIC CHARGE ON THE HEPATIC UPTAKE OF MACROMOLECULES IN THE RAT LIVER

  1990cited by this paper
• Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues.

  1990cited by this paper
• Reduction of immunogenicity by covalent modification of murine and rabbit immunoglobulins with oxidized dextrans of low molecular weight.

  1990cited by this paper
• Biochemical and biopharmaceutical properties of macromolecular conjugates of uricase with dextran and polyethylene glycol.

  1990cited by this paper
• Preparation of dextran-bound recombinant hirudin and its pharmacokinetic behaviour.

  1990cited by this paper
• Covalent fixation of hemoglobin to dextran phosphates decreases its oxygen affinity.

  1990cited by this paper
• Effect of the Chemical Modification of Dextran on the Degradation by Dextranase

  1990cited by this paper
• Disposition Characteristics of Macromolecules in Tumor-Bearing Mice

  1990cited by this paper
• Alteration of biopharmaceutical properties of drugs by their conjugation with water-soluble macromolecules: Uricase-dextran conjugate

  1990cited by this paper
• Intrahepatic Delivery of Glutathione by Conjugation to Dextran

  1989cited by this paper
• Dextran prodrugs — structure and stability in relation to therapeutic activity

  1989cited by this paper
• High-performance size-exclusion chromatographic procedure for the determination of fluoresceinyl isothiocyanate dextrans of various molecular masses in biological media.

  1989cited by this paper
• Physicochemical properties and antitumor activities of polymeric prodrugs of mitomycin C with different regeneration rates

  1989cited by this paper
• Macromolecular prodrugs. XIV. Absorption characteristics of naproxen after oral administration of a dextran T-70-naproxen ester prodrug in pigs

  1989cited by this paper
• Macromolecular Prodrugs. XVI. Colon-Targeted Delivery—Comparison of the Rate of Release of Naproxen from Dextran Ester Prodrugs in Homogenates of Various Segments of the Pig Gastrointestinal (GI) Tract

  1989cited by this paper
• Preparation and characterization of a soluble glutathione-dextran conjugate

  1989cited by this paper
• Comparison of efficacy, toxicity and pharmacokinetics of free adriamycin and adriamycin linked to oxidized dextran in rats.

  1989cited by this paper
• Macromolecular prodrugs. XIII. Determination of the ionization constant of dextran by potentiometric titration and from kinetic analysis of the hydrolysis of dextran indomethacin ester conjugates

  1989cited by this paper
• Control of pharmaceutical properties of soybean trypsin inhibitor by conjugation with dextran. I: Synthesis and characterization.

  1989cited by this paper
• Some Aspects of the Application of Dextran in Prodrug Design

  1988cited by this paper

• Scalable desolvation synthesis, storage stability, and comprehensive biophysical characterization of human hemoglobin nanoparticles as a potential hemoglobin-based oxygen carrier.

  2026cites this paper
• Dextran-based stimuli-responsive hydrogels for smart dressings in wound healing

  2026cites this paper
• Antibody-drug conjugates as multimodal therapies against hard-to-treat cancers.

  2025cites this paper
• Tuned all-atom model reveals structural and dynamical properties of concentrated dextran solutions

  2025cites this paper
• Folic acid grafted amphiphilic dextran-b-poly(ε-benzyloxycarbonyl- l-lysine) micelles for drug’s pH-responsive release

  2025cites this paper
• Nanomedicine's shining armor: understanding and leveraging the metal-phenolic networks

  2025cites this paper
• Dynamic proton coupled electron transfer quenching as a sensing modality in fluorescent probes

  2025cites this paper
• Polysaccharides carrier as oral colon-specific drug delivery for colon cancer treatment

  2025cites this paper
• Carbohydrate biopolymer-based nanocomposites as strategic modality in addressing brain cancer.

  2025cites this paper
• Optimized Fluorescent pH-Sensitive Dextran Conjugates Enable Ratiometric Measurement of Cerebral Blood pH In Vivo and In Situ.

  2025cites this paper
• Dendrimers in Medicine: Properties, Drug Encapsulation Mechanisms and Applications

  2025cites this paper
• The design principle of natural polysaccharide hydrogels for promoting wound healing: a prospective review.

  2025cites this paper
• Targeted cancer treatment using folic acid-functionalized carbohydrate polymers: A new era in nanomedicine

  2025cites this paper
• Synergistic effect of dextran and ergosterol: A venue for fabricating a water-in-oil Pickering emulsion gel as a solid fat substitute in cream cheese

  2025cites this paper
• The Role of Natural Hydrogels in Enhancing Wound Healing: From Biomaterials to Bioactive Therapies

  2025cites this paper
• ZIF-8-Based Composites for Enhanced Biofilm Penetration and Synergistic Antibacterial Therapy against Periodontal Pathogens.

  2025cites this paper
• Advancements in hydrogels: A comprehensive review of natural, synthetic, and hybrid innovations for wound healing.

  2025cites this paper
• Dextran-based Drug Delivery Approaches for Lung Diseases: A Review.

  2024cites this paper
• A Comprehensive Review of Nanoparticles: From Classification to Application and Toxicity

  2024cites this paper
• Drug Efficacy Comparison of pH-Sensitive and Non-pH-Sensitive Taxol Delivery Nanoparticles in Cancer Therapy.

  2024cites this paper
• Polysaccharide nanoadjuvants with precise drug composition for enhanced STING-mediated APC activation

  2024cites this paper
• Dextran Macroinitiator for Synthesis of Polysaccharide-b-Polypeptide Block Copolymers via NCA Ring-Opening Polymerization.

  2024cites this paper
• Polymeric biomaterials for wound healing

  2023cites this paper
• Biocompatible scaffolds based on collagen and oxidized dextran for endothelial cell survival and function in tissue engineering

  2023cites this paper
• Fabrication of Drug-Loaded Torus-Shaped Alginate Microparticles and Kinetic Analysis of Their Drug Release.

  2023cites this paper
• Tetrameric Antibody Complexes and Affinity Tag Peptides for the Selective Immobilization and Imaging of Single Quantum Dots.

  2023cites this paper
• Development of carbon monoxide-releasing molecules conjugated to polysaccharides (glyco-CORMs) for delivering CO during obesity.

  2023cites this paper
• Fluorescent Dextran Applications in Renal Intravital Microscopy

  2023cites this paper
• Role of charge in enhanced nuclear transport and retention of graphene quantum dots

  2023cites this paper
• PSMA-specific degradable dextran for multiplexed immunotargeted siRNA therapeutics against prostate cancer.

  2022cites this paper
• Designing the Surface Chemistry of Inorganic Nanocrystals for Cancer Imaging and Therapy

  2022cites this paper
• Dextrans and dextran derivatives as polyelectrolytes in layer-by-layer processing materials - A review.

  2022cites this paper
• Dextran-based micro- and nanobiomaterials for drug delivery and biomedical applications

  2022cites this paper
• Remote magnetic actuation of cell signalling for tissue engineering

  2022cites this paper
• Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer

  2022cites this paper
• Dextran-Mimetic Quantum Dots for Multimodal Macrophage Imaging In Vivo, Ex Vivo, and In Situ.

  2022cites this paper
• Regioselective synthesis of polysaccharide-amino acid ester conjugates.

  2021cites this paper
• Applications of Polymers in Delivery of Biologics

  2021cites this paper
• Selective Capture of Anti‐N‐glucosylated NTHi Adhesin Peptide Antibodies by a Multivalent Dextran Conjugate

  2021cites this paper
• Elucidating the degradation mechanism of a self-degradable dextran-based medical adhesive.

  2021cites this paper
• Self-assembly of dextran - b - deoxycholic acid polyester copolymers: Copolymer composition and self-assembly procedure tune the aggregate size and morphology.

  2021cites this paper
• Dextran-based nanomaterials in drug delivery applications

  2021cites this paper
• Engineering of stimuli-responsive self-assembled biomimetic nanoparticles.

  2021cites this paper
• Polysaccharide peptide conjugates: Chemistry, properties and applications.

  2021cites this paper
• Recent advances in the production of biomedical systems based on polyhydroxyalkanoates and exopolysaccharides.

  2021cites this paper
• Biological Conjugates: Potential Role in Biomedical and Pharmaceutical Applications

  2021cites this paper
• Curdlan-based nanomaterials in drug delivery applications

  2021cites this paper
• Acetalated dextran based nano- and microparticles: synthesis, fabrication, and therapeutic applications.

  2021cites this paper
• Multilayer co-encapsulation of probiotics and γ-amino butyric acid (GABA) using ultrasound for functional food applications

  2021cites this paper
• Hemocompatible, biocompatible and antifouling Acylated dextran-g-polytetrahydrofuran graft copolymer with silver nanoparticles: Synthesis, characterization and properties.

  2021cites this paper
• Biocompatible, Hemocompatible and Antibacterial Acylated Dextran-g-polyisobutylene Graft Copolymers with Silver Nanoparticles

  2021cites this paper
• Nanotechnology-Based Antimicrobial and Antiviral Surface Coating Strategies

  2021cites this paper
• Oxidized polysaccharides for anticancer-drug delivery: What is the role of structure?

  2021cites this paper
• Synergistic control of mechanics and microarchitecture of 3D bioactive hydrogel platform to promote the regenerative potential of engineered hepatic tissue.

  2021cites this paper
• PD-L1 siRNA Theranostics With a Dextran Nanoparticle Highlights the Importance of Nanoparticle Delivery for Effective Tumor PD-L1 Downregulation

  2021cites this paper
• Natural and Synthetic Biopolymers in Drug Delivery and Tissue Engineering

  2021cites this paper
• Biodegradable polymers in drug delivery and oral vaccination

  2021cites this paper
• Microbial Cell Factories for Biomanufacturing of Polysaccharides

  2021cites this paper
• Injectable bio-responsive hydrogel for therapy of inflammation related eyelid diseases

  2021cites this paper
• Enhancing cisplatin anticancer effectivity and migrastatic potential by modulation of molecular weight of oxidized dextran carrier.

  2021cites this paper
• Natural polymers-based light-induced hydrogels: Promising biomaterials for biomedical applications

  2020cites this paper
• Site-selective modification of exendin 4 with variable molecular weight dextrans by oxime-ligation chemistry for improving type 2 diabetic treatment.

  2020cites this paper
• Selective Oxidation of 2-Hydroxypropyl Ethers of Cellulose and Dextran: Simple and Efficient Introduction of Versatile Ketone Groups to Polysaccharides.

  2020cites this paper
• Carboxymethyl group activation of dextran cross-linked superparamagnetic iron oxide nanoparticles

  2020cites this paper
• Dendrimers in targeted drug delivery applications: a review of diseases and cancer

  2020cites this paper
• A bio-inspired injectable hydrogel as a cell platform for real-time glycaemic regulation.

  2020cites this paper
• Purification, Characterization, and Biocatalytic and Antibiofilm Activity of a Novel Dextranase from Talaromyces sp.

  2020cites this paper
• 3D printing of hydrogels: Rational design strategies and emerging biomedical applications

  2020cites this paper
• Dextran-Functionalized Semiconductor Quantum Dot Bioconjugates for Bioanalysis and Imaging.

  2020cites this paper
• Dextran-based Nanomicelle System with Directly Ester-bound Gadolinium Chelates as a Magnetic Resonance Imaging Contrast Agent for Tumor Detection

  2020cites this paper
• Biopolymer Microparticles Prepared by Microfluidics for Biomedical Applications.

  2020cites this paper
• Rational design and latest advances of polysaccharide-based hydrogels for wound healing.

  2020cites this paper
• Nano ZnO imprinted dextran hybrid poly (N-isopropylacrylamide)/poly ethylene glycol composite hydrogels for in vitro release of ciprofloxacin

  2020cites this paper
• Reproducible, biocompatible medical materials from biologically derived polysaccharides: Processing and Characterization

  2020cites this paper
• Natural polymers

  2019cites this paper
• Synthesis and self-assembly of polysaccharide-b-elastin-like polypeptide bioconjugates

  2019cites this paper
• Amino Acid-Substituted Dextran-Based Non-Viral Vectors for Gene Delivery.

  2019cites this paper
• 4-Sulfonatocalixarene-induced nanoparticle formation of methylimidazolium-conjugated dextrans: Utilization for drug encapsulation.

  2019cites this paper
• TRAIL‐Inspired Multivalent Dextran Conjugates Efficiently Induce Apoptosis upon DR5 Receptor Clustering

  2019cites this paper
• Polysaccharide nanomicelles as drug carriers

  2019cites this paper
• Spirocyclic Acetal-Modified Dextran as a Flexible pH-Sensitive Solubility-Switching Material.

  2019cites this paper
• Aus dem Institut für Transfusionsmedizin der Medizinischen Fakultät Charité – Universitätsmedizin Berlin DISSERTATION One-pot Formulation of Protein Submicron Particles and Their Haemocompatibility zur Erlangung des akademischen Grades Doctor rerum medicinalium (Dr. rer. medic.) vorgelegt der Me

  2019cites this paper
• Carbohydrate-based nanomaterials for biomedical applications.

  2019cites this paper
• Application of Natural Polysaccharides in Pharmaceutics

  2019cites this paper
• Controlling the degradation of an oxidized dextran-based hydrogel independent of the mechanical properties.

  2019cites this paper
• Effective systemic siRNA delivery using dual-layer protected long-circulating nanohydrogel containing an inorganic core.

  2019cites this paper
• methylimidazolium-conjugated dextrans: Utilization for drug encapsulation

  2019cites this paper
• Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.

  2019cites this paper
• Sugar-based biopolymers as novel imaging agents for molecular magnetic resonance imaging.

  2019cites this paper
• Block copolymers containing dextran and deoxycholic acid polyesters. Synthesis, self-assembly and hydrophobic drug encapsulation.

  2019cites this paper
• Dextramabs: A Novel Format of Antibody‐Drug Conjugates Featuring a Multivalent Polysaccharide Scaffold

  2019cites this paper
• Synthesis of Dextran–Phenoxodiol and Evaluation of Its Physical Stability and Biological Activity

  2019cites this paper
• Application and mechanism of manganese-coated caramelization nanospheres for active targeting in hepatobiliary tumors.

  2019cites this paper
• Polymeric Nanomaterials

  2019cites this paper
• Electrically conductive biomaterials based on natural polysaccharides: Challenges and applications in tissue engineering.

  2019cites this paper
• Sugar-based biopolymers as novel imaging agents for molecular MRI

  2019influential citation
• Nanomedicine: Bioavailability, Biotransformation and Biokinetics.

  2019cites this paper
• Molecular structure of dextran sulphate sodium in aqueous environment

  2018cites this paper
• Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation

  2018cites this paper
• Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.

  2018cites this paper